BiochemProbe — Life Science Research Reagents

PZM-21 free base · Synonyms: PZM 21 · PZM21

PZM21 is a potent and selective μ opioid receptor agonist.

For research use only. Not for human or veterinary use.

Research area Neurological Disease
Purity >98% Stock Inquire

PZM-21 structure

CAS No.: 1997387-43-5

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
100 mg USD 420.00 BP-01957-100mg In stock Get quote
250 mg USD 720.00 BP-01957-250mg In stock Get quote
500 mg USD 1,120.00 BP-01957-500mg In stock Get quote
1 g USD 1,620.00 BP-01957-1g In stock Get quote
5 g Inquire BP-01957-5g Inquire Inquire

Need another size or custom synthesis? Request a quote.

Description

PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM.

Biological activity

In Vitro PZM21 has no detectable κOR or nociceptin receptor agonist activity-it is actually an 18 nM κOR antagonist-while it is a 500-fold weaker δOR agonist, making it a selective μOR agonist. At hERG, PZM21 has an IC50 of between 2 and 4 μM, 500- to 1,000-fold weaker than its potency as a μOR agonist. Signalling by PZM21 and other μOR agonists appears to be mediated primarily by the heterotrimeric G protein Gi/o, as its effect on cAMP levels is eliminated by pertussis toxin and no activity is observed in a calcium release assay. In Vivo PZM21 is a potent Gi activator with exceptional selectivity for μOR and minimal β-arrestin-2 recruitment. PZM21 is efficacious for the affective component of analgesia versus the reflexive component and is devoid of respiratory depression in mice at equi-analgesic doses. PZM21 displays dose-dependent analgesia in a mouse hotplate assay, with a per cent maximal possible effect (% MPE) of 87% reached 15 min after administration of the highest dose of drug tested. PZM21 has a long-lasting analgesic effect on CNS mediated-pain responses, but does not cause respiratory depression and constipation, two key side effects of opioid agonists.

Identifiers

SMILES
C[C@@H](CC1=CSC=C1)NC(=O)NC[C@H](CC1=CC=C(O)C=C1)N(C)C
InChIKey
MEDBIJOVZJEMBI-YOEHRIQHSA-N

Specifications

MW (average)
361.5020
Formula
C19H27N3O2S
CAS No.
1997387-43-5
Physical state
Solid
Color
white to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Manglik A, et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature. 2016 Sep 8;537(7619):185-190.
[2]. Kostic M, et al. Biasing Opioid Receptors and Cholesterol as a Player in Developmental Biology.
[3]. Araldi D, et al. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat. Neuroscience. 2018 Oct 17;394:60-71.

Same research area

Search Neurological Disease